Skip to content
AnalystLens

METLIFE INC 8-K Report, Corporate Update (Feb 17, 2026)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed February 17, 2026
Period End
February 17, 2026
In the record · 2016–202610-K1110-Q328-K249

MET filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 249 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Aug ’17Aug ’17
  2. Leadership change8-K · Mar ’23Mar ’23
  3. Leadership change8-K · Mar ’25Mar ’25

01—Abstract

Summary

Summary of the 8-K filed February 17, 2026. Cited figures are marked; the original filing is the authoritative source.

MetLife, Inc. (NYSE: MET) filed an 8-K on February 17, 2026 under Item 8.01 (Other Events) to announce its first quarter 2026 preferred stock dividend actions.

The filing is routine in nature: the company declared dividends on four series of non-cumulative preferred stock, including a semi-annual dividend on Series D (5.875%a fixed-to-floating rate), quarterly dividends on Series E (5.625%) and Series F (4.75%), and a quarterly dividend on its floating rate Series A. No financial results, guidance, strategic transactions, or leadership changes are disclosed in the filing. The declared dividends are payable March 16, 2026, to holders of record as of February 27, 2026.

The Series A dividend of $0.31501229b per share is conditional: it is subject to MetLife confirming it has met the financial tests in the Series A certificate of designations, which the company expects to announce on or about March 5, 2026. The NYSE has not yet set an ex-dividend date for Series A and will do so only after that confirmation. Investors in the Series A preferred should watch for this confirmation before relying on the payment.

For investors, the main significance is the continued payment of preferred dividends, which signals that MetLife is meeting its obligations to preferred holders and is maintaining its capital distributions. Because these are non-cumulative instruments, missed dividends would not accrue, so the conditional Series A payment is the one item that warrants monitoring. The filing does not provide information on earnings, capital ratios, or the company's broader financial condition.

02—Key points

Key Highlights

  1. Declared a semi-annual dividend of $29.375 per share on the 5.875% fixed-to-floating rate non-cumulative Series D preferred stock ($1,000 liquidation preference).
  2. Declared a quarterly dividend of $0.3515625 per depositary share on the 5.625% non-cumulative Series E preferred stock (NYSE: MET PRE), equal to $351.5625 per share.
  3. Declared a quarterly dividend of $0.296875 per depositary share on the 4.75% non-cumulative Series F preferred stock (NYSE: MET PRF), equal to $296.875 per share.
  4. Declared a quarterly dividend of $0.31501229 per share on the floating rate non-cumulative Series A preferred stock (NYSE: MET PRA), subject to final confirmation of financial tests expected around March 5, 2026.
  5. All dividends are payable March 16, 2026, to shareholders of record as of February 27, 2026.
  6. The NYSE has not yet set an ex-dividend date for Series A; it will do so after the confirmatory announcement.
  7. The filing contains no earnings, guidance, or material corporate events; it is a routine preferred dividend disclosure.

03—Questions

Frequently Asked Questions

  1. When will the preferred dividends be paid?

    The dividends are payable March 16, 2026, to shareholders of record as of Friday, February 27, 2026. The record dates fall on a weekend, which is why the cutoff is February 27.

  2. Is the Series A floating rate preferred dividend guaranteed?

    No, not yet. The Series A dividend is subject to MetLife confirming it has met the financial tests specified in the Series A certificate of designations. The company anticipates making that confirmation on or about March 5, 2026.

  3. Are these preferred dividends cumulative?

    No. All four series are non-cumulative, meaning that if a dividend is not declared for a period, the company has no obligation to pay it later.

  4. What do the per-share amounts mean for depositary share holders?

    Series E and Series F are issued as depositary shares, with each depositary share representing a 1/1,000th interest in a preferred share. Holders receive $0.3515625 per depositary share for Series E and $0.296875 per depositary share for Series F.

  5. Does this filing indicate any change in MetLife's financial condition?

    No. The filing only reports routine dividend declarations. It contains no earnings results, capital metrics, guidance, or other financial information about the company's operations.

04—Continue

← View all 8-K filings